Open AccessCorrection to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
Author(s) -
Tadej Battelino,
Zsolt Bosnyák,
Thomas Danne,
B. N. Mukherjee,
Steve Edelman,
Valérie Pilorget,
Pratik Choudhary,
Éric Renard,
Richard M. Bergenstal
Publication year - 2020
Publication title -
diabetes therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.907
H-Index - 33
ISSN - 1869-6961
DOI - 10.1007/s13300-020-00820-2
Subject(s) - insulin degludec , insulin glargine , medicine , continuous glucose monitoring , basal insulin , type 2 diabetes , diabetes mellitus , basal (medicine) , type 1 diabetes , endocrinology
In the original publication, the timing of baseline CGM assessment was incorrectly stated in the text in two instances; it is correct in Fig. 1.